Fisher Asset Management’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$49.6M Sell
1,918,497
-220,899
-10% -$6.23M 0.01% 233
2026
Q2
$66M Sell
2,139,396
-51,008
-2% -$1.26M 0.02% 213
2026
Q1
$47.3M Buy
2,190,404
+240,616
+12% +$5.2M 0.02% 244
2025
Q4
$46.5M Buy
1,949,788
+1,220,635
+167% +$24.9M 0.02% 244
2025
Q3
$9.9M Buy
729,153
+640,990
+727% +$6.66M ﹤0.01% 410
2025
Q2
$718K Sell
88,163
-49,475
-36% -$423K ﹤0.01% 738
2025
Q1
$1.08M Buy
+137,638
New +$1.6M ﹤0.01% 668

Other funds holding RCUS

Fisher Asset Management's RCUS Position: Q3 2026 in Review

Fisher Asset Management reduced its Arcus Biosciences (RCUS) stake by 10% in Q3 2026, selling an estimated $6.23M and leaving 1,918,497 shares worth $49.6M. The position accounts for 0.01% of the portfolio, ranked #233.

Fisher Asset Management first reported a position in RCUS in Q1 2025 and has held it in 7 quarters since. The position peaked at $66M in Q2 2026. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Fisher Asset Management held 1,918,497 shares of Arcus Biosciences worth $49.6M as of Q3 2026.
  • Fisher Asset Management sold 220,899 Arcus Biosciences shares in Q3 2026, an estimated $6.23M.
  • Arcus Biosciences made up 0.01% of Fisher Asset Management's portfolio in Q3 2026, its #233 holding.
  • Fisher Asset Management first reported a position in Arcus Biosciences in Q1 2025 and has held it in 7 quarters since.
  • Fisher Asset Management's Arcus Biosciences position peaked at $66M in Q2 2026.
  • 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Fisher Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.